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Background: As high-risk cardiac patients frequently remain within hospital while waiting for surgery, the aim of
the present study was to determine the role of preoperative length of hospital stay on mediastinitis, and also, to
assess contemporary risk factors for this complication.
Methods: The source population consisted of 6653 consecutive patients undergoing coronary bypass surgery, valve
surgery, or both between September 2000 and September 2009 at a single tertiary care hospital. A retrospective
cohort analysis was used to assess the effect of 18 preoperative variables, including length of stay, on mediastinitis.
Results: Mediastinitis developed in 108 patients (1.6%) resulting in an in-hospital mortality rate of 13.9%.
Independent predictors of mediastinitis included obesity (2.59, CI 1.58-4.23), COPD (2.44, CI 1.55-3.84), diabetes (2.16,
CI 1.44-3.24), and impaired estimated glomerular filtration rate. Preoperative hospital stay was also found to be an
independent risk factor leading to a 15% increased risk of mediastinitis per week of stay. The primary wound
pathogen was coagulase negative staphylococcus (82%) followed by multi-flora isolates (49%), but was unrelated to
hospital stay.
Conclusions: In addition to the traditional risk factors, prolonged preoperative hospital stay is also a significant and
potentially modifiable predictor for the development of mediastinitis following cardiac surgery. All efforts should be
made to minimize the delay in operating on hospitalized patients awaiting heart surgery.Background
Despite improved surgical techniques and preoperative
antibiotic prophylaxis, surgical site infections, more spe-
cifically mediastinitis, remains a potentially fatal compli-
cation after open-heart surgery with an incidence of
0.6% - 2.65% [1-5]. In-hospital mortality ranges from 14
to 23%, even when mediastinitis is correctly treated
[6,7], and it has been shown to have a significant impact
on hospital costs [8].
Well-described risk factors for mediastinitis include
diabetes mellitus, chronic obstructive pulmonary disease
(COPD), obesity, as well as harvesting of bilateral in-
ternal mammary arteries [9-12]. In many Canadian
Provinces, patients too precarious to wait at home, often* Correspondence: kevin.lachapelle@muhc.mcgill.ca
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distribution, and reproduction in any mediumstay in hospital for an extended period before surgery
can be performed. There are many reasons for this situ-
ation, which may include restricted operating room ac-
cess, lack of ICU beds, or delays due to more urgent
cases [13]. Knowing that hospital stay may predispose a
patient to skin colonization with more virulent hospital-
based pathogens, we hypothesized that a prolonged
preoperative hospital stay would also result in an in-
creased incidence of mediastinitis. The consequences of
prolonged preoperative hospital stay on cardiac surgical
outcome have not been previously studied.
The aim of the present study, therefore, was to identify
preoperative risk factors for mediastinitis in current
practice, and to assess the role of preoperative length of
stay on deep sternal wound infection in the context of
increasing surgical delays.d Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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Study population and study design
The study population comprised of 6653 consecutive
adult patients undergoing median sternotomy during the
period between September 2000 and September 2009 at
a single tertiary care hospital in Montreal, Canada. Heart
transplant patients, adult congenital and patients receiv-
ing ventricular assist devices were excluded from this
cohort.
Preoperative variables that were collected prospectively
as part of a clinical registry maintained by the Division of
Cardiac Surgery included the following: age, sex, obesity,
ejection fraction, type of operation (coronary, valve, or
combined procedures), smoking, diabetes mellitus, COPD,
chronic renal failure (CRF), preoperative creatinine, pre-
operative estimated glomerular filtration rate (eGFR), con-
gestive heart failure (CHF), hypertension, redo surgery,
left main coronary disease, preoperative hospital length of
stay, operative status (elective, urgent, or emergent), and
Parsonnet score. Any missing data was obtained by
reviewing individual patient charts at the time of the
study. This study was approved by the McGill University
Health Center Research Ethics Board.
Definitions
Mediastinitis was defined according to the Center for
Disease Control and Prevention criteria [14]; however,
all suspected cases were also confirmed by CT scan im-
aging of the chest. Superficial wound infections sparing
the sternum were not classified as mediastinitis. Esti-
mated glomerular filtration rate was derived using the
CKD-Epi study equation using the preoperative serum
creatinine value closest to the date of surgery [15]. Pre-
operative hospital length of stay was calculated as the
number of days from hospital admission (under any
service) until the day of surgery. The calculation of
Parsonnet score has been previously described [16].
Obesity was defined as BMI greater than 30 kg/m2. Op-
erative status was categorized as: emergent if the pa-
tient’s cardiac disease dictated that surgery be performed
within hours outside of regular operating hours; urgent
if the patient’s cardiac disease required the patient to re-
main in the hospital until the operation was performed;
and elective if the patient’s clinical status allowed dis-
charge from the hospital and readmission at a later date
[17].
Infection prophylaxis and operative technique
All patients receive a 2% chlorhexidine gluconate shower
and mupirocin 2% ointment to both nostrils the night
prior to surgery as well as the morning of. Antibiotic
prophylaxis is given as Cefazolin 2 grams intravenously
30 minutes before skin incision and again after 4 hours.
Additional doses are given every 4 hours, if required,until termination of the surgery. Patients undergoing
valvular surgery, have a penicillin allergy, or who are
methicillin-resistant Staphylococcus aureus (MRSA) posi-
tive receive Vancomycin 1 gram intravenously 30 minutes
before skin incision. Removal of excess hair at the ster-
num, groin, and appropriate leg is performed with clippers
in the operating suite. All patients are disinfected with
Baxedine© (Chlorhexidine 2% w/ 70% V/V alcohol solu-
tion) in the operating room prior to incision.
Cardiopulmonary bypass was performed using non-
pulsatile flow. Cold blood cardioplegia was used to in-
duce and maintain cardioplegic arrest. Patients are kept
at mild hypothermia throughout cardiopulmonary by-
pass (lowest nasopharyngeal temperature 32°C). The left
internal mammary artery, when required as per discre-
tion of the surgeon, was harvested as a pedicle using
electrocautery in all cases. Sternal closure was performed
using seven or eight No.5 stainless steel wires. In the im-
mediate 24 hr postoperative period, an insulin infusion
titrated to a blood glucose defined by the intensive care
physician was administered if blood glucose levels ex-
ceed 10 mmol/L. The insulin infusion was discontinued
once the patient was transferred to the cardiac surgical
intermediate care unit.Statistical analysis
Patient characteristics are expressed as proportions,
means and standard deviations, or medians and inter-
quartile ranges, as appropriate. A natural log transform-
ation was made to Parsonnet score, since its distribution
was highly skewed.
Logistic regression was used to examine the associ-
ation of various demographic, comorbidity, and pre-
operative laboratory variables with mediastinitis. Models
were adjusted for covariates that were significant at the
univariate level. The Hosmer Lameshow Goodness-of-fit
test was used to assess calibration of the logistic regres-
sion model, by assessing the observed and predicted
event rates in subgroups (deciles) of the model popula-
tion. A p-value threshold of 0.05 was used to determine
statistical significance. All analyses were carried out
using SAS version 9.1 (SAS Institute Inc., Cary, NC).Results
Patient characteristics and incidence of mediastinitis
During the 9-year period from September 2000 to
September 2009, 6653 patients underwent cardiac sur-
gery resulting in 108 (1.6%) cases of mediastinitis. Of
these, 87 included coronary artery bypass grafting sur-
gery (CABG) with use of a single internal mammary ar-
tery, 16 included CABG without any mammary artery,
while 5 were isolated valve cases. The overall distribu-
tion of operations included isolated CABG at 64.9%,
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CABG in 14.9% of cases.
Table 1 describes the baseline characteristics of the
study population. The mean age of the patients was 66.1
years with the majority having a systolic ejection fraction
of more than 50%. The mean Parsonnet score was
18.7 ± 13.3 leading to a mean predicted mortality risk
of 7.6%.
Risk factors for mediastinitis
Preoperative predictors for mediastinitis are shown in
Table 2. Univariate risk factors were advanced age,
Parsonnet score, CHF, COPD, diabetes, hypertension, left
main disease, peripheral vascular disease, obesity, decreas-
ing eGFR, operative status, and prolonged preoperative
length of stay. After adjusting for all significant factors in
univariate analyses only obesity, COPD, diabetes, pre-
operative length of stay, and decreasing eGFR wereTable 1 Baseline preoperative characteristicsa
Variable All patients
N=6653
Age, years (SD) 66 (10.9)
Male Sex, n (%) 4647 (69.9)
Obesity (BMI > 30 kg/m2), n (%) 461 (6.9)
% EF
>50%, n (%) 3410 (60.6)
30-50%, n (%) 1499 (26.7)
<30%, n (%) 715 (12.7)
Type of Surgery
CABG only, n (%) 4319 (64.9)
Combined valve + CABG, n (%) 986 (14.9)
Valve only, n (%) (Heart transplant, congenital,
and ventricular assist devices excluded)
1024 (15.4)
Smoking (current/<1 year abstinent), n (%) 85 (1.3)
Diabetes, n (%) 1642 (24.7)
COPD, n (%) 703 (10.6)
CRF, n (%) 644 (9.7)
Mean preoperative creatinine, μmol/L (SD) 111 (73)
Mean eGFR, ml/min/1.73 m2, (SD) 65 (22)
CHF, n (%) 2458 (37.0)
Hypertension, n (%) 4216 (63.4)
Redo surgery, n (%) 499 (7.5)
Left main disease, n (%) 1018 (15.3)
Duration of Preoperative Hospital Stay, median (IQR) 2 (2–3)
Emergency surgery, n (%) 571 (8.6)
Parsonnet score, mean (SD) 18.7 (13.3)
a For definitions please refer to reference 16.
CHF congestive heart failure, COPD chronic obstructive pulmonary disease, CRF
chronic renal failure, EF ejection fraction, eGFR estimated glomerular filtration
rate, IQR interquartile range, SD standard deviation.independent predictors of mediastinitis, with obesity being
the most significant (OR 2.59, 95% CI 1.58-4.23). Standard
eGFR cut-points of 30 and 60 ml/min/1.73 m2 were used
in Table 2; however, there was no eGFR cut-off value
above which the risk of mediastinitis became significant,
since the relationship between both elements remained
linear across all eGFR values (data not shown). The area
under the receiver operating characteristic curve for our
fully adjusted model was 0.734. This implies that our
model, which uses easy to collect variables, is acceptable
to accurately discriminate those at risk of mediastinitis
after cardiac surgery. The Hosmer Lameshow Goodness-
of-Fit test also showed good calibration of our model
(Chi-square 10.48, degrees of freedom=6, p-value=0.11).
Furthermore, a dose–response relationship was found
with regards to preoperative hospital stay, whereby a
stay beyond 7 days was associated with a 2.43-fold in-
creased risk of mediastinitis compared to a preoperative
stay of 4–7 days which increased this risk by 1.39 times
(Table 3).
In-hospital mortality and management of mediastinitis
There were 381 in-hospital deaths. The in-hospital actuar-
ial mortality rate for cardiac surgery cases complicated by
mediastinitis was 13.9% compared to 5.6% in those pa-
tients without mediastinitis (OR 2.72, 95% CI 1.56 - 4.75).
Management of patients with mediastinitis was either
by non-operative or operative means. Twenty-eight pa-
tients who had a stable clinical picture were treated by
conservative management involving vacuum-assisted
closure therapy with intravenous antibiotics. When the
overall clinical picture displayed evidence of deterior-
ation due to unremitting infection or lack of improve-
ment secondary to an unstable sternum, operative
revision was performed. Sternal debridement and re-
wiring was utilized in 16 patients, while sternal debride-
ment with pectoralis muscle flap advancement was
performed in 64 cases of mediastinitis.
Bacteriology
Of the 108 cases of postoperative mediastinitis, no bac-
teriology could be found in 4 of the cases after chart re-
view. In the remaining 104 cases, the most common
pathogen was coagulase negative Staphylococcus (82%)
followed by Enterococcus (22%). Mixed flora was found
in 49% of cases of mediastinitis (Table 4). There was no
significant relationship between bacterial pathogen and
preoperative hospital stay.
Discussion
Although cardiac surgery is currently undergoing in-
novative changes in its methods of exposure to allow
less invasive approaches to valve and coronary surgery,
the standard median sternotomy has not changed since
Table 2 Preoperative factors associated with mediastinitis based on cohort analysis
Covariate Univariate OR (95% CI) Adjusted OR (95% CI)*
Age (per 10 years) 1.28 (1.06-1.53) NS
Parsonnet Score (per ln) 1.80 (1.34-2.40) NS
CHF 1.53 (1.04-2.25) NS
COPD 3.44 (2.24-5.30) 2.44 (1.55-3.84)
Diabetes 2.89 (1.96-4.24) 2.16 (1.44-3.24)
Hypertension 2.68 (1.63-4.41) NS
Left Main Disease 1.63 (1.03-2.59) NS
PVD 2.72 (1.64-4.50) NS
Obesity 4.33 (2.74-6.85) 2.59 (1.58-4.23)
Estimated GFR (ml/min/1.73 m2)
≥60 Reference Reference
30-59 1.86 (1.20-2.90) 1.56 (1.00-2.45)
<30 3.53 (2.12-5.87) 2.41 (1.42-4.09)
Operative Status:
Urgent vs elective 2.20 (1.40-3.46) NS
Emergent vs elective 1.44 (0.65-3.22) NS
Preoperative length of stay (per week) 1.17 (1.05-1.31) 1.15 (1.02-1.31)
* Adjusted model includes all variables significant at the univariate level. Hosemer-Lameshow Goodness-of-Fit Test Chi-square=10.48, df=6, p-value=0.11.
CHF congestive heart failure, COPD chronic obstructive pulmonary disease, ln natural log, OR odds ratio, PVD peripheral vascular disease, NS non-significant.
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mediastinitis is rare, it continues to be a significant
source of morbidity, mortality, and cost. The incidence
of mediastinitis in this contemporary patient population
was 1.6%, which is consistent with the range of 0.6%-
2.65% reported in studies performed within the last dec-
ade [1-5]. Our in-hospital actuarial mortality rate of
13.9% is on the lower range of the 15-20%, which has
been observed previously [3,4]. In contrast to previous
studies, we did not limit our analysis to CABG proce-
dures only, but included combined CABG and valve, as
well as valve only. The procedure type was not associ-
ated with mediastinitis (data not shown).
In accordance with other studies our analysis found
that diabetes [6,10], COPD [2,19], impaired preoperative
kidney function [4,20], and obesity [2,4,6,9,12] to be in-
dependent risk factors for mediastinitis. The mechanism
by which diabetes leads to mediastinitis is unclear. There
is evidence relating cardiac surgical wound infections
with perioperative hyperglycemia [21,22]. Such elevatedTable 3 Incidence and risk of mediastinitis according to preo
Covariate N




OR odds ratio.glucose levels have been found to be associated with a
pro-inflammatory process leading to increased suscepti-
bility to infection as well as organ dysfunction [22]. In
this study, COPD increased the risk of mediastinitis by
2.4 folds. The coughing induced by COPD is hypothe-
sized to lead to sternal instability, therefore, increasing
the risk of bacterial translocation and hence, sternal in-
fection [23]. Previous studies have related preoperative
renal failure on dialysis with deep sternal wound infec-
tions following cardiac surgery [4,20]. In this study, we
used eGFR as a determinant of renal function, as this
measurement is more accurate than serum creatinine
alone. Our results illustrate that even impaired preopera-
tive kidney function is an independent predictor for the
complication. Our cohort analysis, as in others, also
found obesity to be the most significant risk factor for
deep sternal wound infections. According to Milano et al.
the fixed prophylactic antibiotic doses used in adult sur-
gery may be inadequate given the large volumes of distri-
bution in the obese [24]. Another plausible mechanismperative length of stay
Cases of mediastinitis (%) Adjusted OR (95% CI)
71 (1.4) Reference
17 (1.9) 1.39 (0.81-2.37)
20 (3.3) 2.43 (1.47-4.02)
Table 4 Prevalence of microorganisms isolated from
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sternal halves apart and predisposing to sternal dehiscence.
This study demonstrates that extended preoperative
hospital stay is a significant risk factor for mediastinitis
by both univariate and adjusted models. Each week of
hospital stay preoperatively was associated with a 15%
increased risk of mediastinitis. This is a novel and also
potentially modifiable risk factor. To our knowledge only
one previous study revealed that the interval between
hospital admission and operation to be a risk factor for
deep sternal wound infection [25]. Conklin et al. also ob-
served that a preoperative hospital length of stay more
than 7 days was associated with a 4.4-fold increased risk
of overall surgical site infections after cardiac surgery
[26]. Although a prolonged preoperative stay could lead
to colonization of antibiotic-resistant nosocomial patho-
gens, our analysis revealed no significant relationship in
the distribution of bacteria found on culture with the
operative status or preoperative length of stay. Perhaps,
a more plausible explanation is that in-patients are often
kept fasting while awaiting urgent surgery, and therefore,
may be nutritionally deficient in the perioperative
period. It is well established that adequate caloric intake
is necessary for proper wound healing. Hennessey et al.
found that hypoalbuminemia was an independent risk
factor for surgical site infections after gastrointestinal
surgery, and that an albumin less than 30 mg/dL was as-
sociated with deeper infections [27]. As a result, patients
with critical coronary disease awaiting urgent surgery in
the hospital could be predisposed to mediastinitis based
on their nutritional status.
Our results clearly indicate a need to reduce preopera-
tive wait-times for cardiac surgery. Efforts such as
delaying elective cases to prioritize in-hospital patients,
as well as, discharging patients well enough to go home
may help to minimize this risk factor.
As for the bacteriologic analysis, the most commonly
isolated sternal pathogen comprised of coagulase-
negative staphylococcus while Staphylococcus aureus waspresent in only 9% of wound cultures. Moreover, 49% of
mediastinitis cases grew multiple organisms. These re-
sults differ from recent studies where S. aureus was the
predominant bacteria present in 32-50% of isolates with
coagulase negative staphylococcus present in 19-24% of
cases [1,2,5]. Although it is possible that the unusually
high frequency of coagulase negative staphylococcus is
due to cutaneous contamination, this result helps to
clarify our lower than expected hospital mortality rate of
mediastinitis since surgical site infections from S.
epidermidis present a more indolent course. More im-
portantly, this analysis brings into question the effective-
ness of using 1st generation cephalosporins as antibiotic
prophylaxis in cardiac surgery since they do not ad-
equately guard against coagulase negative staphylococ-
cus. According to the Society of Thoracic Surgeons
practice guidelines [28], Class I recommendations support
use of a beta-lactam antibiotic, more commonly Cefazolin,
as first-line for standard cardiac surgical prophylaxis
where the incidence of MRSA is low. This has been our
routine practice. Given the high rate of S. epidermidis in
sternal wound infections demonstrated in the current
study, we therefore suggest the use of Vancomycin as sur-
gical prophylaxis in patients with a preoperative hospital
stay beyond 3 days since they are at greater risk of deep
sternal wound infections.
Limitations
There are several limitations to our study. First, it is a
retrospective study and as such, the results may be af-
fected by confounding variables not controlled for in the
study. In addition, there was no pre-specified follow-up
of patients to assess wound infection following surgery,
which could allow for patients with delayed mediastinitis
to be lost to follow-up. However, as a tertiary care cen-
ter, the majority of patients presenting at a peripheral
hospital with a potential surgical complication are re-
ferred back to our institution. Currently, our database
does not contain cardiopulmonary bypass and aortic
cross clamp times for all patients, thus we could not
evaluate its impact on mediastinitis risk. Another limita-
tion is the failure of our database to capture the cause
for the prolonged preoperative hospital stay. This is
most often multifactorial. As our institution is a referral
center, patients often come from afar, and therefore, re-
main in hospital until they can be operated on. The lim-
ited number of ICU beds in a public healthcare system
also prevents prompt surgical intervention, thereby, fur-
ther prolonging the hospital stay. For example, performing
an emergency cardiac operation overnight often results in
cancellations in the operating schedule the following day.
Moreover, it is possible that patients remaining in hospital
awaiting surgery did so because of an impaired medical
condition (pneumonia, sepsis, CHF, etc.) that was not
Leung Wai Sang et al. Journal of Cardiothoracic Surgery 2013, 8:45 Page 6 of 7
http://www.cardiothoracicsurgery.org/content/8/1/45captured by our analysis. However, our study found no
relationship between higher preoperative mortality risk as
indicated by the Parsonnet score with the risk of
mediastinitis. Lastly, this study was performed at a single
institution, which may limit generalizability. However, this
same circumstance also ensures that all patients were
subjected to the same pre- and postoperative variables
that could affect infection.
Conclusions
The present data demonstrates that in addition to the
traditional risk factors for mediastinitis, a prolonged pre-
operative hospital length of stay is also an important
predictor of deep sternal wound infections. Minimizing
the delay for hospitalized patients awaiting cardiac sur-
gery, as well as optimizing the prophylactic antibiotic regi-
men in these patients should be further explored, as it
likely represents a modifiable risk factor for mediastinitis.
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